Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Trial to Determine the Role of FDG-PET Imaging in Clinical Stages IA/IIA Hodgkin's Disease

NCT00943423 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00943423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00943423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Trial to Determine the Role of FDG-PET Imaging in Clinical Stages IA/IIA Hodgkin's Disease
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 31, 2003
Completion date
December 31, 2028
Enrollment
602 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma